Lyras Pharma ApS is a Danish APS based in Aalborg, operating in the Manufacture of other general-purpose machinery n.e.c. sector. Incorporated in 2025, the company reported revenue of 557,7 t kr. in its latest annual filing.
In its most recent annual report (2025), Lyras Pharma ApS reported a gross profit of 557,7 t kr.. The bottom line showed a net profit of 432,7 t kr., and the EBITDA margin stood at 100%.
At the end of 2025, equity financed 41.4% of the balance sheet, and current assets covered short-term debt 1.7 times.
Frequently asked questions
What is the CVR number of Lyras Pharma ApS?
Lyras Pharma ApS is registered with CVR / Virk under CVR 45525813.
What is the revenue of Lyras Pharma ApS?
Lyras Pharma ApS reported revenue of 557,7 t kr. in 2025.
Who is the CEO of Lyras Pharma ApS?
Rasmus Mortensen is the CEO of Lyras Pharma ApS, in role since 2026.
Who is the chairman of Lyras Pharma ApS?
Mads Kristoffer Storgaard Mehlsen chairs the board of Lyras Pharma ApS.
Where is Lyras Pharma ApS headquartered?
Lyras Pharma ApS's registered address is Lyngvej 7.
